Pharma AI

NVIDIA says Japanese partners are deploying its stack across healthcare, drug discovery and vision AI, signaling a deeper push into national AI infrastructure.

FDA and EMA publish 10 joint guiding principles for AI in pharmaceuticals as EU AI Act implementation approaches, reshaping drug development regulations.

Eli Lilly, GSK, and Pfizer announce multi-year AI partnerships with startups Chai Discovery, Noetik, and Boltz for biologics design, cancer prediction, and drug discovery applications.